Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H16N5S.Br |
| Molecular Weight | 414.322 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Br-].CC1=C(C)N=C(S1)[N+]2=NC(=NN2C3=CC=CC=C3)C4=CC=CC=C4
InChI
InChIKey=AZKSAVLVSZKNRD-UHFFFAOYSA-M
InChI=1S/C18H16N5S.BrH/c1-13-14(2)24-18(19-13)23-21-17(15-9-5-3-6-10-15)20-22(23)16-11-7-4-8-12-16;/h3-12H,1-2H3;1H/q+1;/p-1
| Molecular Formula | BrH |
| Molecular Weight | 80.912 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C18H16N5S |
| Molecular Weight | 334.418 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/16216776
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16216776
Thiazolyl Blue is a membrane-permeable yellow dye that is reduced by mitochondrial reductases in living cells to form the dark blue product. The net positive charge on Thiazolyl Blue appears to be the predominant factor involved in their cellular uptake via the plasma membrane potential. Thiazolyl Blue is used as a direct indicator of cytotoxicity (such as for screening cancer drugs), proliferation and apoptosis. Thiazolyl Blue is also an electron acceptor used for studying NADP-dependent dehydrogenases. Thiazolyl Blue reduction is associated not only with mitochondria, but also with the cytoplasm and with nonmitochondrial membranes including the endosome/lysosome compartment and the plasma membrane. Biological Applications: cell viability assay; microbial growth assays; DNA quantification assays; tissue viability assays; detecting enzymes; measuring membrane potential; treating Alzheimer’s disease, asthma, cancer. Because Thiazolyl Blue forms an insoluble formazan it has usually been applied in endpoint assays.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Succinate dehydrogenase Sources: https://www.ncbi.nlm.nih.gov/pubmed/16216776 |
|||
Target ID: Oxidoreductases Sources: https://www.ncbi.nlm.nih.gov/pubmed/16216776 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Exocytosis of MTT formazan could exacerbate cell injury. | 2012-06 |
|
| Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity. | 2004-10 |
|
| Inactivation of aconitase during the apoptosis of mouse cerebellar granule neurons induced by a deprivation of membrane depolarization. | 2003-02-15 |
|
| The use of thiazolyl blue for the detection of dehydrogenases on starch gels. | 1966-10 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:51:34 GMT 2025
by
admin
on
Mon Mar 31 19:51:34 GMT 2025
|
| Record UNII |
EUY85H477I
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000141562
Created by
admin on Mon Mar 31 19:51:34 GMT 2025 , Edited by admin on Mon Mar 31 19:51:34 GMT 2025
|
PRIMARY | |||
|
60102
Created by
admin on Mon Mar 31 19:51:34 GMT 2025 , Edited by admin on Mon Mar 31 19:51:34 GMT 2025
|
PRIMARY | |||
|
367079
Created by
admin on Mon Mar 31 19:51:34 GMT 2025 , Edited by admin on Mon Mar 31 19:51:34 GMT 2025
|
PRIMARY | |||
|
DTXSID60889338
Created by
admin on Mon Mar 31 19:51:34 GMT 2025 , Edited by admin on Mon Mar 31 19:51:34 GMT 2025
|
PRIMARY | |||
|
298-93-1
Created by
admin on Mon Mar 31 19:51:34 GMT 2025 , Edited by admin on Mon Mar 31 19:51:34 GMT 2025
|
PRIMARY | |||
|
EUY85H477I
Created by
admin on Mon Mar 31 19:51:34 GMT 2025 , Edited by admin on Mon Mar 31 19:51:34 GMT 2025
|
PRIMARY | |||
|
53233
Created by
admin on Mon Mar 31 19:51:34 GMT 2025 , Edited by admin on Mon Mar 31 19:51:34 GMT 2025
|
PRIMARY | |||
|
206-069-5
Created by
admin on Mon Mar 31 19:51:34 GMT 2025 , Edited by admin on Mon Mar 31 19:51:34 GMT 2025
|
PRIMARY | |||
|
C022616
Created by
admin on Mon Mar 31 19:51:34 GMT 2025 , Edited by admin on Mon Mar 31 19:51:34 GMT 2025
|
PRIMARY | |||
|
SUB93395
Created by
admin on Mon Mar 31 19:51:34 GMT 2025 , Edited by admin on Mon Mar 31 19:51:34 GMT 2025
|
PRIMARY | |||
|
64965
Created by
admin on Mon Mar 31 19:51:34 GMT 2025 , Edited by admin on Mon Mar 31 19:51:34 GMT 2025
|
PRIMARY | |||
|
7300
Created by
admin on Mon Mar 31 19:51:34 GMT 2025 , Edited by admin on Mon Mar 31 19:51:34 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |